Edwards Lifesciences Corporation (NYSE:EW) dropped -0.32% and closed the trade at $ 116.60. The company recorded a trading capacity of 1.48 million shares above its three months average daily volume of 1.41 million shares. During the last trade, shares reached to high price of $117.17 and touched the low price of $116.14. The stock’s 50-day moving average is noted at $114.60 and its 200-day moving average is stands at $103.38.
Additionally, the company has a PE ratio of 48.18 and has EPS of 2.42. The company has market capitalization of $24.82B.
Currently Edwards Lifesciences Corporation (EW) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “18″ Analysts”. “1” rated “Sell” for the company. “7” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $122.95 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $140.00 however minimum price target advised by analysts is $94.00. The Median price target for the stock is measured at $127.50.
Presently, Analysts decided consensus EPS estimate of $0.67 for present quarter and one month ago projected EPS estimate was at $0.67. If we take a look at back 3 month ago, consensus EPS estimate was $0.64.
A current consensus EPS estimate for next quarter is at $0.74 and 3 month ago EPS forecast was $0.72. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.74.
For current fiscal year, most recent EPS estimate is set at $2.88 based on Analyst consensus and three month ago consensus EPS opinions was at $2.77. During period one month ago, consensus EPS forecast was decided at $2.88.
A current consensus EPS projection for next fiscal year is observed at $3.40 and one month ago consensus EPS forecast was at $3.40. Take a look at back three month ago, consensus EPS estimate opinions was decided at $3.28 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 18 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 7 advised the “Hold” rating about this stock. 1 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 18 said a “Buy Rating” and 0 announced “Overweight Rating”. 8 advised “Hold Rating” regarding the stock. 1 announced “Sell Rating” and 0 disclosed “Underweight Rating”.